#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Aplastic anaemia Choroidal dystrophy Hepatitis B Mastocytosis Pulmonary alveolar haemorrhage Cardiac arrest Glomerulonephritis Kaposi's sarcoma Lymphangiosarcoma Glycogen storage disease type V Cushing's syndrome Adenocarcinoma gastric Congenital generalised lipodystrophy Fibrosarcoma metastatic Neuroblastoma recurrent More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Basic Information Gastrointestinal stromal tumour – Trials in Disease Familial amyotrophic lateral sclerosis Leiomyosarcoma – Life with Disease Alternating hemiplegia of childhood – Trials in Disease Ocular melanoma – Trials in Disease Primary hyperoxaluria – Basic Information Ehlers-Danlos syndrome – Trials in Disease Gaucher’s disease type III Chondrosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chloroprocaine Hydrochloride Calcium Oxybate NIZUBAGLUSTAT Rezafungin Acetate Clofarabine Mk-0482 Cdr132L ABY-271 Bms-986288 Remdesivir Prasterone Mirabegron Escitalopram Oxalate ADS-019 13N-AMMONIA Ciclesonide Aclidinium Bromide Dacomitinib Hexaminolevulinate Piperacillin Sodium More therapies…

    Learn about Your Condition

    Anxiety Colorectal adenocarcinoma Hypochromic anaemia Cystic fibrosis Arteriovenous graft thrombosis Rectal cancer recurrent Endocrine disorder Asymptomatic HIV infection Haemoglobinuria Prostate cancer metastatic Pancreatitis relapsing Pleomorphic liposarcoma Essential hypertension Retinal neovascularisation Tuberous sclerosis complex More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. NZOZ Neuro- Kard Ilkowski i Partnerzy Spółka Partnerska…

NZOZ Neuro- Kard Ilkowski i Partnerzy Spółka Partnerska Lekarzy

Ul. Wierzbowa 2/2, Poznan, 61-853, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Zilucoplan Sodium
    Poland

  • Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    • Cetirizine Dihydrochloride
    • Methylprednisolone
    Bulgaria Croatia Czechia Poland Romania Spain

  • Study of XPro1595 for Patients with Early Alzheimer’s Disease and Inflammation Markers

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia of the Alzheimer’s type uncomplicated
    Investigated Drugs:
    • Pegipanermin
    Czechia France Germany Poland Slovakia Spain

  • Study on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Pantoprazole
    • Ibuprofen
    • Dronabinol
    Czechia Germany Poland Spain

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Milvexian
    • Andexanet Alfa
    • Apixaban
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13

  • Study on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • (R)-1-(Tert-Butyl)-N-(8-(2-((1-Methyl-1H-Pyrazol-4-Yl)Amino)Pyrimidin-4-Yl)-2-(Oxetan-3-Yl)-2,3,4,5-Tetrahydro-1H-Benzo[C]Azepin-5-Yl)-1H-1,2,3-Triazole-4-Carboxamide
    • Diroximel Fumarate
    • Gadoteric Acid
    Bulgaria Czechia Germany Italy Poland Romania +1

  • Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pain
    • Diabetic neuropathy
    Investigated Drugs:
    • Odm-111
    • Paracetamol
    Bulgaria Czechia Germany Hungary Poland

  • Study on Ublituximab for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Ublituximab
    Croatia Poland

  • Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Obicetrapib
    Bulgaria Croatia Czechia Denmark Finland Germany +7
Previous Page
1 2 3 4

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!